Suppositories "Diclovit" are anti-inflammatory drugs and are a derivative of phenylacetic acid. The active substance in the specified drug is diclofenac sodium. They have an antipyretic, analgesic and analgesic effect.
Diclovit suppositories are a non-steroidal drug that inhibits prostaglandin biosynthesis. They are involved in the development of inflammatory symptoms such as edema and fever. The use of this tool can reduce pain in the presence of various rheumatic diseases, as well as diseases of a non-rheumatic nature. "Diclovit" suppositories relieve pain that occurs in the postoperative period, and also after receiving various kinds of injuries, they suppress platelet aggregation. From the body, the drug is excreted along with bile and through the kidneys.
"Diclovit", instructions for use
This drug is used in the presence of inflammatory diseases such as rheumatism, rheumatoid arthritis, chronic gouty arthritis, ankylosing spondylitis. They also help effectively in the presence of neuralgia, sciatica, myalgia, lumbago, diseases of extraarticular tissues (rheumatic lesions of the soft tissues, bursitis, tendovaginitis), in the presence of post-traumatic syndromes, which are accompanied by inflammatory processes and to reduce postoperative pain. Diklovit suppositories help during gout attacks, in the presence of primary dysmenorrhea, adnexitis, renal and hepatic colic, ENT infections, migraine attacks and residual pneumonia.
Contraindications to the use of this drug
The presence of hypersensitivity to the components of "Diclovit" suppositories, with impaired blood formation. It is also not recommended to take this remedy for people who have a stomach or duodenal ulcer, “aspirin” bronchial asthma, as well as during pregnancy and children under six years of age.
Possible side effects
"Diclovitis" suppositories can cause disorders in the body, such as nausea and vomiting, stomach cramps and diarrhea, anorexia, flatulence, dyspepsia. Fatigue, headaches, and dizziness may appear. In the hematopoietic system, side effects of the use of this drug are the appearance of thrombocytopenia, leukopenia, agranulocytosis, hemolytic anemia. Also, Diclovit suppositories can cause local irritation. On the skin there is a rash, itching, hives and burning.
The specified drug causes an increase in lithium and digoxin in the blood, as well as indirect anticoagulants, quinolone derivatives and oral antidiabetic drugs. The toxicity of cyclosporine, methotrexate increases, there is a likelihood of developing gastrointestinal bleeding, there is a risk of developing hyperkalemia on the background of potassium-sparing diuretics, and the effect of diuretics decreases. The concentration in the blood decreases if acetylsalicylic acid is prescribed together with these suppositories.
When using suppositories, cases of overdose with this agent have not been registered. If the drug is taken orally, the manifestations of its overdose will be dizziness, hyperventilation, the appearance of headaches, blurred consciousness. In children, convulsions, myoclonic gastrointestinal tract disorders, and impaired renal and hepatic function may appear. In the presence of these cases, symptomatic treatment is performed.
Since the use of the drug causes a slight decrease in the reaction, it is not recommended to work with mechanisms and drive vehicles after its use. Also, "Diklovit" candles should not be prescribed to people who have problems in the work of the kidneys and liver, heart failure and when performing work that requires increased attention and reaction.